Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Revvity
RVTY
$12.9B
| $1.18M | ﹤0.01% |
24,106
+863
| +4% | +$41.2K |
|
2352
CALL
McKesson
MCK
$105B
| $1.18M | ﹤0.01% |
7,500
-31,800
| -81% | -$5.14M |
|
|
OMED
2353
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.18M | ﹤0.01% |
117,537
+105,972
| +916% | +$1.24M |
|
2354
PUT
Hewlett Packard
HPE
$72B
| $1.17M | ﹤0.01% |
118,718
-277,870
| -70% | -$2.33M |
|
|
CHMT
2355
DELISTED
Chemtura Corporation
CHMT
| $1.16M | ﹤0.01% |
44,767
-87,833
| -66% | -$2.24M |
|
2356
CALL
AstraZeneca
AZN
$246B
| $1.16M | ﹤0.01% |
20,750
-114,500
| -85% | -$6.88M |
|
2357
CALL
Hasbro
HAS
$13.7B
| $1.16M | ﹤0.01% |
14,500
-3,400
| -19% | -$253K |
|
2358
PUT
Edison International
EIX
$26.9B
| $1.16M | ﹤0.01% |
16,300
+14,000
| +609% | +$908K |
|
2359
PUT
Ross Stores
ROST
$80.8B
| $1.16M | ﹤0.01% |
20,300
-34,000
| -63% | -$1.89M |
|
2360
PUT
Murphy Oil
MUR
$5.12B
| $1.16M | ﹤0.01% |
46,200
-113,400
| -71% | -$2.27M |
|
|
CAVM
2361
DELISTED
Cavium, Inc.
CAVM
| $1.16M | ﹤0.01% |
18,924
+13,593
| +255% | +$785K |
|
|
ETFC
2362
PUT
DELISTED
E*Trade Financial Corporation
ETFC
| $1.15M | ﹤0.01% |
48,100
-6,000
| -11% | -$145K |
|
2363
PUT
Domino's
DPZ
$11.8B
| $1.15M | ﹤0.01% |
8,800
-10,800
| -55% | -$1.29M |
|
2364
ENI
E
$80.3B
| $1.15M | ﹤0.01% |
38,400
+37,500
| +4,167% | +$1.07M |
|
2365
Hanover Insurance
THG
$7.73B
| $1.15M | ﹤0.01% |
12,807
+4,368
| +52% | +$361K |
|
2366
Valmont Industries
VMI
$9.52B
| $1.15M | ﹤0.01% |
9,335
+7,718
| +477% | +$856K |
|
|
2367
PUT
Hasbro
HAS
$13.7B
| $1.14M | ﹤0.01% |
14,300
+4,800
| +51% | +$357K |
|
2368
REX American Resources
REX
$1.43B
| $1.14M | ﹤0.01% |
124,782
-26,562
| -18% | -$229K |
|
|
TTM
2369
PUT
DELISTED
Tata Motors Limited
TTM
| $1.14M | ﹤0.01% |
39,400
-17,400
| -31% | -$439K |
|
2370
PUT
Western Union
WU
$2.2B
| $1.14M | ﹤0.01% |
59,900
-100,300
| -63% | -$1.8M |
|
2371
PUT
ProShares UltraShort QQQ
QID
$251M
| $1.14M | ﹤0.01% |
490
+406
| +483% | +$1.09M |
|
2372
CALL
Amphenol
APH
$206B
| $1.13M | ﹤0.01% |
79,600
+69,200
| +665% | +$899K |
|
2373
CALL
Dillards
DDS
$10.1B
| $1.13M | ﹤0.01% |
13,500
+2,200
| +19% | +$165K |
|
2374
Acuity Brands
AYI
$10.7B
| $1.13M | ﹤0.01% |
5,198
-4,595
| -47% | -$948K |
|
2375
Woodward
WWD
$21.1B
| $1.13M | ﹤0.01% |
21,763
+3,109
| +17% | +$148K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.